Minerva Neurosciences Faces Delisting Concerns
Ticker: NERV · Form: 8-K · Filed: Oct 11, 2024 · CIK: 1598646
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
Related Tickers: NERV
TL;DR
Minerva Neurosciences might get delisted, check NASDAQ status.
AI Summary
Minerva Neurosciences, Inc. filed an 8-K on October 11, 2024, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company's principal executive offices are located at 1500 District Avenue, Burlington, MA 01803. The filing date is October 11, 2024, with the earliest event reported on October 8, 2024.
Why It Matters
This filing indicates potential issues with Minerva Neurosciences' compliance with stock exchange listing requirements, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued trading on a major exchange.
Key Players & Entities
- Minerva Neurosciences, Inc. (company) — Registrant
- October 8, 2024 (date) — Earliest event reported
- October 11, 2024 (date) — Filing date
- 1500 District Avenue, Burlington, MA 01803 (location) — Principal executive offices
- NASDAQ (company) — Stock exchange
FAQ
What specific listing rule or standard has Minerva Neurosciences failed to satisfy?
The filing does not specify the exact rule or standard that Minerva Neurosciences has failed to satisfy, only that it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard'.
What is the date of the earliest event reported in this 8-K?
The earliest event reported is October 8, 2024.
Where are Minerva Neurosciences' principal executive offices located?
Minerva Neurosciences' principal executive offices are located at 1500 District Avenue, Burlington, MA 01803.
What is the filing date of this 8-K report?
The 8-K report was filed on October 11, 2024.
What is the company's IRS Employer ID Number?
The company's IRS Employer ID Number is 26-0784194.
Filing Stats: 618 words · 2 min read · ~2 pages · Grade level 14.5 · Accepted 2024-10-11 16:10:54
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share NERV The Nasdaq
- $35 million — ted Securities was below the minimum of $35 million required for continued listing on The N
Filing Documents
- d844510d8k.htm (8-K) — 23KB
- 0001193125-24-236726.txt ( ) — 139KB
- nerv-20241008.xsd (EX-101.SCH) — 3KB
- nerv-20241008_lab.xml (EX-101.LAB) — 17KB
- nerv-20241008_pre.xml (EX-101.PRE) — 11KB
- d844510d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MINERVA NEUROSCIENCES, INC. Dated: October 11, 2024 By: /s/ Geoffrey Race Name: Geoffrey Race Title: President 2